REQUEST A DEMO
Total
USD $0.00
« Back to previous page

China Healthcare Sector Report 2016 3rd Quarter

An EMIS Insights Industry Report
EMIS is an ISI Emerging Markets Group Company
Date: July 2016
Pages: 79
Available in: English

China's healthcare system is hospital-centric, with public hospitals delivering approximately 90% of the inpatient and outpatient care consumed in the country today in both hospitals and basic medical institutions. Nearly 40% of hospitals’ revenue is generated by pharmaceutical sales. The Chinese healthcare market has been growing strongly, focusing on the treatment of chronic diseases, such as cancer, diabetes and respiratory conditions. China's current shortage of quality public healthcare services has resulted in a rising demand for private medical care. However, private healthcare is underdeveloped and faces difficulties in finding quality doctors, as many of the best ones are employed by public hospitals via exclusivity clauses. Doctors in public hospitals are seriously underpaid, which makes them dependent on additional unofficial income from pharmaceutical companies and patients. Hospitals generate nearly half of their revenues from drug sales, and despite being public, receive grossly inadequate funding from the government.

 

This report provides a complete and detailed analysis of the healthcare sector for China. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

  • Understand the key elements at play in the healthcare sector in China
  • Access forecasts for growth in the sector
  • View key data on healthcare spending and health insurance in China
  • Crystallise the forces both driving and restraining this sector in China
  • Build a complete perspective on sector trade, investment and employment
  • Understand the competitive landscape and who the major players are
  • View M&A activity and major deals
  • Gain an understanding of the regulatory environment for the sector in China
  • Build a clear picture of trends and issues for sub-sectors (e.g. medical institutions, medical devices and pharmaceuticals).

 

See below for a complete table of report contents:

China Healthcare Sector Report 2016 3rd Quarter - Page 1
Buy full report USD 495.00 Payment methods include:

DOWNLOAD A SAMPLE
Have a question?

Email us at: emisstoresupport@emis.com

SEE BELOW FOR A COMPLETE TABLE OF REPORT CONTENTS:

China Healthcare Sector Report 2016 3rd Quarter -  Page 3
China Healthcare Sector Report 2016 3rd Quarter -  Page 4
China Healthcare Sector Report 2016 3rd Quarter -  Page 19
China Healthcare Sector Report 2016 3rd Quarter -  Page 24
ONCE YOU HAVE COMPLETED YOUR PURCHASE,
YOU WILL BE ABLE TO DOWNLOAD THIS REPORT IMMEDIATELY AS A PDF
If you have any questions, please contact customerenquires@emis.com
Buy full report
Need ongoing access to company, industry or country information?